Literature DB >> 29427698

Correlations of the glycemic variability with oxidative stress and erythrocytes membrane stability in patients with type 1 diabetes under intensive treatment.

Ricardo Rodrigues1, Luciana Alves de Medeiros2, Lucas Moreira Cunha2, Mario da Silva Garrote-Filho2, Morun Bernardino Neto3, Paulo Tannus Jorge4, Elmiro Santos Resende4, Nilson Penha-Silva2.   

Abstract

OBJECTIVES: This study aimed to evaluate the correlations of glycemic variability with erythrocyte membrane stability parameters and oxidative stress markers in patients with type 1 diabetes mellitus (T1DM) under intensive treatment.
MATERIAL AND METHODS: 90 patients with T1DM and under intensive treatment of the disease were evaluated in relation to anthropometric indices, records of glycemic averages and parameters of glycemic variability, biochemical dosages (glucose, uric acid, lipidogram, glycated hemoglobin, microalbuminuria, creatinine and iron) reticulocyte count, erythrocyte membrane stability parameters and oxidative stress markers (thiobarbituric acid reactive substances, TBARS, and glutathione reductase, GR).
RESULTS: Indicators of glycemic variability in the short and long term showed correlations with parameters of membrane stability and markers of oxidative stress (GR). In addition, the comparison of these same parameters between the subgroups consisting of quartiles of GV or glycemic control also showed significant differences.
CONCLUSION: In the T1DM patients studied here, glycemic variability showed correlations with oxidative stress and erythrocyte membrane stability variables. This corroborates the hypothesis that glycemic fluctuations interfere with lipid peroxidation and cell membrane behavior, emphasizing its participation in mechanisms related to the development of chronic complications of diabetes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Erythrocytes; Glycemic variability; Membrane stability; Oxidative stress; Type 1 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29427698     DOI: 10.1016/j.diabres.2018.01.031

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

Review 2.  New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk.

Authors:  Jin J Zhou; Daniel S Nuyujukian; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2021-03-02       Impact factor: 2.931

3.  The Product of Red Blood Cells and Hematocrit Can Be Used as a Novel Indicator of Impaired Fasting Blood Glucose Status.

Authors:  Ling Feng; Haishan Chen; Jianhui Chen; Chongxiang Xiong; Xiaofei Shao; Xin Wang; Jing Ning; Zhicong Xiang; Xuan Wang; Tong Chen; Hua Xiao; Hongjuan Tang; Xiaolin Li; Guobao Hong; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-27       Impact factor: 3.168

Review 4.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

5.  Red cell distribution width and erythrocyte osmotic stability in type 2 diabetes mellitus.

Authors:  Maria Aparecida Knychala; Mario da Silva Garrote-Filho; Breno Batista da Silva; Samantha Neves de Oliveira; Sarah Yasminy Luz; Manuela Ortega Marques Rodrigues; Nilson Penha-Silva
Journal:  J Cell Mol Med       Date:  2021-02-16       Impact factor: 5.310

6.  Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.

Authors:  Hae Jin Kim; In Kyung Jeong; Kyu Yeon Hur; Soo-Kyung Kim; Jung Hyun Noh; Sung Wan Chun; Eun Seok Kang; Eun-Jung Rhee; Sung Hee Choi
Journal:  Diabetes Metab J       Date:  2022-03-17       Impact factor: 5.893

7.  Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes.

Authors:  Rachel Brandt; Minsun Park; Kristen Wroblewski; Lauretta Quinn; Esra Tasali; Ali Cinar
Journal:  Diabetologia       Date:  2021-06-17       Impact factor: 10.460

Review 8.  Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?

Authors:  Harriet Warnes; Rebecca Helliwell; Sam Matthew Pearson; Ramzi A Ajjan
Journal:  Diabetes Ther       Date:  2018-09-12       Impact factor: 2.945

9.  The erythrocyte membrane stability is associated with sleep time and social jetlag in shift workers.

Authors:  Kely Raspante Cerqueira Teixeira; Luciana Alves de Medeiros; Jordane Amaral Mendes; Emília Rezende Vaz; Thúlio Marquez Cunha; Erick P de Oliveira; Nilson Penha-Silva; Cibele Aparecida Crispim
Journal:  PLoS One       Date:  2019-09-23       Impact factor: 3.240

Review 10.  The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.

Authors:  Zhen Wei Marcus Tong; Emma Grant; Stephanie Gras; Melanie Wu; Corey Smith; Helen L Barrett; Linda A Gallo; Kirsty R Short
Journal:  FEBS J       Date:  2021-07-31       Impact factor: 5.622

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.